Metri Bio CEO Ashley Abel co-authors review in Nature Biomedical Engineering

Metri Bio CEO and co-founder Ashley Abel is co-first author of a new review in Nature Biomedical Engineering on endometrial modeling and endometriosis. The paper traces how endometrial models have evolved, from early 2D cell cultures to next-generation organoids and multi-lineage assembloids, and explains why these human-based systems capture physiology that animal models often miss. […]

Metri Bio CEO Ashley Abel on why endometriosis research needs to start with the biology

In a new op-ed for the Boston Herald, Metri Bio CEO and co-founder Ashley Abel argues that endometriosis is almost certainly not one disease, and that treating it as one has kept care stuck in place for decades. Drawing on the research she began at Yale, she makes the case for modeling the disease with […]